Highlights from IAS 2015
Here is some news coming out of of the International AIDS Conference in Vancouver, Canada this week:
- Definitive scientific evidence to support earlier initiation of HIV treatment: Results from two landmark studies support the case for initiating HIV treatment soon after diagnosis. Read more about this research, and other major scientific developments.
- Preview of new WHO ARV Guidelines: With a growing body of evidence supporting the benefits of earlier treatment initiation for HIV-infected individuals, as well as evidence for the use of antiretrovirals to prevent new HIV infections, the World Health Organization (WHO) is embarking on an extensive review and updating its guidelines for ARV use. WHO HIV Director Gottfried Hirnschall previewed the new guidelines currently in development, and their implications for individuals, health systems and the future of the epidemic. Find out more.
- WHO launches new guidelines on HIV testing services: With only 51% of people living with HIV aware of their status globally, WHO released new “Consolidated guidelines on HIV testing services” that cover new and existing recommendations centered on lay provider-delivered HIV testing services and advise countries on how best to target. Find out more.
- Michel Sidibé, Executive Director of UNAIDS, says that the ambitious 90-90-90 targets are achievable: Data from large African studies examining the population impact of treatment as prevention approaches suggest that the objectives of testing and treating 90% of those eligible is achievable meaning. Find out more.
- Inviting and tracing male partners helps to get them involved in HIV counselling and testing: In a trail that included actively inviting and tracing male partners of pregnant women newly diagnosed with HIV, there was a 74% uptake of couple HIV counselling and testing by male partners. Find out more.
- No evidence of HIV transmission from people with fully suppressed viral load to their partners: An interim analysis of the HPTN 052 study showed a 96% reduction in the risk of HIV transmission. Find out more.